Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
retatrutide phase 3 trial results ⭐️topline from TRIUMPH-1, a clinical evaluating # retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with obesit Adults Are GLP-1 drugs changing Variant:50µg
Are GLP-1 drugs changing what's on Miami restaurant menus? | Miami Herald
This was the first time treatment actually changed my trajectory.” “My PCP told me I'd probably be denied and didn't want to fight it
Adults
Variant:50µg
If it has to “grow into” this valuation with an exit P/E of 25x by 2030, it should grow its EPS by 20% CAGR
US$ 21.90
US$ 20.47
US$ 29.29
US$ 26.67
US$ 20.71
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
